Sentiment Survey
|
|
|
|
|
|
|
|
|
|
|
|
Investment Grade:
|
|
Comments(0)
|
(0)
|
(0)
|
Ranking History
Headlines
- Analyst Comments: Alexza Pharma, Joy Global, Kookmin Bank, MEMC Electronic Materials, Home Diagnostics
Sep 04, 2008 02:49 PM
- Analyst Comments: Alexza Pharma, Abbott Lab, Metabasis, Quicksilver, ASM International
Jun 13, 2008 04:45 PM
- Confidence In The Fed
Jun 10, 2008 12:15 PM
- Analyst Comments: China Life, Newfield, OPNET, Novatel, Alexza, LDS Solar, Encore
May 14, 2008 07:28 PM
- Analyst Comments: Acergy, Trimeris, Emageon, Dynavax, Newcastle, Kyocera, Alexza Pharma, Kirby Corporation
Mar 19, 2008 08:24 PM
- 52 Week Low's 1/23
Jan 23, 2008 11:27 PM
- Analyst Comments
Dec 27, 2007 04:46 PM
- Endo, Alexza Pharmaceutical In AZ-003 Development, Licensing Pact
Dec 27, 2007 04:29 PM
- Endo, Alexza Pharmaceutical In AZ-003 Development, Licensing Pact
Dec 27, 2007 04:29 PM
- Alexza Names Barron To Board
Dec 19, 2007 06:38 PM
- Alexza Pharmaceuticals Announces Upcoming Conference Participation and Webcasts
Nov 11, 2008 04:15 PM
- Alexza Reports 2008 Third Quarter Financial Results and Updates Development of Product Candidates
Nov 06, 2008 04:05 PM
- Alexza to Announce 2008 Third Quarter Financial Results and Update Its Clinical Pipeline on Thursday, November 6, 2008
Oct 28, 2008 09:15 AM
- Alexza Completes Enrollment in Second Phase 3 Clinical Trial With AZ-004 (Staccato(R) Loxapine) for Acute Agitation
Oct 16, 2008 04:05 PM
- Alexza's Corporate Presentation to be Webcast at the Third Annual JMP Securities Healthcare Focus
Sep 30, 2008 04:00 PM
- Alexza's AZ-004 (Staccato(R) Loxapine) Phase 3 Trial Meets Primary Endpoint of Treating Acute Agitation in Schizophrenic Patients
Sep 02, 2008 04:10 PM
- Alexza Pharmaceuticals Announces Upcoming Webcasts and Conference Participation
Aug 27, 2008 09:01 AM
- Alexza Reports 2008 Second Quarter Financial Results and Updates Development of Product Candidates
Aug 06, 2008 04:31 PM
- Alexza to Announce 2008 Second Quarter Financial Results and Update Its Clinical Pipeline on Wednesday, August 6, 2008
Jul 30, 2008 07:09 PM
- Alexza Initiates Second Phase 3 Clinical Trial for AZ-004 (Staccato(R) Loxapine)
Jul 24, 2008 01:30 PM
- Form 4 Alexza Pharmaceuticals For: Oct 31 Filed by: Simms Michael J (10K)
Nov 04, 2008 06:10 PM
- Form 4 Alexza Pharmaceuticals For: Oct 31 Filed by: Cassella James V (10K)
Nov 04, 2008 06:10 PM
- Form 4 Alexza Pharmaceuticals For: Oct 31 Filed by: Moretti August J (10K)
Nov 04, 2008 06:01 PM
- Form 4 Alexza Pharmaceuticals For: Aug 11 Filed by: KING THOMAS BRAXTON (10K)
Aug 11, 2008 07:04 PM
- Form 4 Alexza Pharmaceuticals For: Jul 09 Filed by: KING THOMAS BRAXTON (10K)
Jul 11, 2008 09:50 PM
- Form 4 Alexza Pharmaceuticals For: Jul 09 Filed by: Cassella James V (10K)
Jul 11, 2008 09:49 PM
- Form 4 Alexza Pharmaceuticals For: Jul 09 Filed by: Moretti August J (10K)
Jul 11, 2008 09:48 PM
- Form 4 Alexza Pharmaceuticals For: May 27 Filed by: Read J Leighton (10K)
May 28, 2008 07:43 PM
- Form 4 Alexza Pharmaceuticals For: May 27 Filed by: PAKIANATHAN DEEPIKA (10K)
May 28, 2008 07:43 PM
- Form 4 Alexza Pharmaceuticals For: May 27 Filed by: STEIN ISAAC (10K)
May 28, 2008 07:43 PM
Analyst Ratings
|
|
Share Performance
|
Period
|
ALXA
|
Compare to S&P
|
| YTD |
-77.75 %
|
-63.55 %
|
| 4 Weeks |
-36.84 %
|
-31.73 %
|
| 12 Weeks |
-66.97 %
|
-54.22 %
|
|
Financial Ratios
Earnings Performance
|
EPS Growth in Last Quarter: -4.65 %
|
|
EPS Growth in Last Year: -28.57 %
|
|
Sales Growth in Last Quarter: -0.01 %
|
|
Sales Growth in Last Quarter: -0.01 %
|
|
|
